Literature DB >> 9829434

Selective removal of cholesterol esters in an arteriosclerotic region of blood vessels with a free-electron laser.

K Awazu1, A Nagai, K Aizawa.   

Abstract

BACKGROUND AND
OBJECTIVE: In advanced atheromatous atherosclerosis, a large amount of lipids, particularly cholesterol esters, accumulates on the arterial wall. The selective removal of cholesterol esters accumulated in the intracellular or extracellular spaces has clinical significance. In the present work, the authors investigated the removal of cholesterol esters by using a free-electron laser (FEL) in an arteriosclerotic region. STUDY DESIGN/
MATERIALS AND METHODS: Thin films of cholesteryl oleate and albumin and the cross section of a rabbit artery were placed on an inverted microscope stage, and the changes caused by the FEL irradiation of 5.75 microm and 6.1 microm, with 1.5-3 mW on average, were monitored continuously by using a CCD camera in real time. RESULTS AND
CONCLUSION: FEL irradiation at a wavelength of 5.75 microm, which is a stretching vibrational mode of the ester, was able to ablate cholesterol esters without affecting albumin. It can also remove cholesterol esters from rabbit arteriosclerotic arterial walls.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9829434     DOI: 10.1002/(sici)1096-9101(1998)23:4<233::aid-lsm6>3.0.co;2-0

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  2 in total

1.  Development of an intravascular laser treatment with an infrared free electron laser. Selective removal of cholesterol ester in carotid atheromatous plaques.

Authors:  Y Nakajima; K Iwatsuki; K Ishii; T Fujinaka; K Awazu; T Yoshimine
Journal:  Interv Neuroradiol       Date:  2008-06-09       Impact factor: 1.610

2.  Degradation of Human Serum Albumin by Infrared Free Electron Laser Enhanced by Inclusion of a Salen-Type Schiff Base Zn (II) Complex.

Authors:  Yuika Onami; Takayasu Kawasaki; Hiroki Aizawa; Tomoyuki Haraguchi; Takashiro Akitsu; Koichi Tsukiyama; Mauricio A Palafox
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.